US Pharma Firms License Chinese Drugs Worth $18 Billion
US pharma firms license $18B in Chinese drugs, enhancing innovation pipelines amid regulatory caution.
US pharma firms license $18B in Chinese drugs, enhancing innovation pipelines amid regulatory caution.
Dogecoin volume surpasses $1 billion with a 46% price surge, driven by institutional interest and whale accumulation.
SEC delays Franklin Ethereum ETF decision, extending deadline to June 2024, impacting ETH market.
Crypto market sees major downturn as geopolitical tensions escalate, Ethereum drops over 10%.
Metaplanet issues $210M bonds to acquire Bitcoin, surpassing 10,000 BTC holdings, led by CEO Simon Gerovich, with strategic endorsement from Michael Saylor.
Coinbase and Gemini pursue EU licenses for expansion, targeting strategic growth in Europe.
Pakistan discusses a national Bitcoin strategy with Michael Saylor, focusing on digital assets and economic policy.
Circle CEO Jeremy Allaire predicts stablecoins nearing a breakout phase, with USDC set for mainstream adoption.
RESOLV stablecoin debuts with backing, alongside Binance’s new DeFi token listings.
Bitcoin mining difficulty drops 0.45% as MARA, CleanSpark focus on BTC accumulation, boosting miner profitability.
End of content
End of content